Promethium Reviews

The CLEAR™ Cryptosystem is an encryption software development kit (SDK) validated by FIPS-140-3, specifically created to safeguard files, streaming media, databases, and network communications through innovative and programmable encryption technology. It seamlessly integrates with all contemporary computing systems, offering an effective and straightforward solution for embedding advanced encryption into current security infrastructures. With its Post-Quantum Cryptography (PQC) capabilities, CLEAR™ ensures robust defense against future cybersecurity challenges, allowing you to secure your data with the most powerful encryption techniques available. This system not only enhances data protection but also allows for swift access and communication across various platforms. Key Features: • PQC Encryption Strength (512bit - 10,240bit) • Ultra Low-Latency Streaming (< 11µs / Packet) • Hyperkey™ Technology with embedded ACL • Multi-Factor / Bio-Metric Symmetric Keys • Plug-N-Play Entropy - CSRNG, QRNG, HRNG Benefits: • Pass cybersecurity audits with best-in-class tools • Share data securely via Sharepoint, Dropbox, and similar services • Protect legacy hardware and older network systems • Extend security to files stored in third-party platforms • Ensure lasting protection for long-term data archival needs, making it a comprehensive choice for organizations looking to the future.

Delska operates as a specialized data center and network service provider, delivering customized IT and networking solutions for enterprises. With a total of five data centers in Latvia and Lithuania—one of which is set to open in 2025—and additional points of presence in Germany, the Netherlands, and Sweden, we create a robust regional ecosystem for data centers and networking. Our commitment to sustainability is reflected in our goal to reach net-zero CO2 emissions by 2030, establishing a benchmark for eco-friendly IT infrastructure in the Baltic region. Beyond traditional services like cloud computing, colocation, and data security, we also introduced the myDelska self-service cloud platform, designed for rapid deployment of virtual machines and management of IT resources, with bare metal services expected soon. Our platform boasts several essential features, including unlimited traffic and fixed monthly pricing, API integration, customizable firewall settings, comprehensive backup solutions, real-time network topology visualization, and a latency measurement map, supporting various operating systems such as Alpine Linux, Ubuntu, Debian, Windows OS, and openSUSE. In June 2024, Delska expanded its portfolio by merging with two companies—DEAC European Data Center and Data Logistics Center (DLC)—which continue to function as separate legal entities under the ownership of Quaero European Infrastructure Fund II. This strategic merger enhances our capacity to provide even more innovative services and solutions to our clients.

Established in 2000, VeraChem LLC is dedicated to advancing the realms of computer-aided drug discovery and molecular design by developing sophisticated computational chemistry methods that integrate groundbreaking scientific principles with real-world research applications. A fundamental component of the company’s approach to product innovation is providing high-performance software solutions paired with comprehensive user assistance. VeraChem’s software currently boasts capabilities such as predicting protein-ligand and host-guest binding affinities, executing rapid and accurate computations of partial atomic charges for drug-like substances, and calculating energies and forces using popular empirical force fields. Furthermore, the software includes features for the automatic generation of alternative resonance forms for drug-like molecules, an efficient conformational search powered by the Tork algorithm, and the automated detection of topological and three-dimensional molecular symmetries. The modular design of VeraChem’s software packages facilitates adaptability and flexibility, allowing users to tailor these tools to meet a variety of research demands effectively. By providing such versatile resources, VeraChem empowers researchers to enhance their investigative efforts in drug discovery.